A large collection of conserved eukaryotic peptidyl-prolyl cis-trans isomerases. Some members of this group are secreted (into the ER).. Localization: Cytoplasmic (by homology) / ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 22 |
NetGPI | no | yes: 0, no: 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
GO:0005737 | cytoplasm | 2 | 3 |
GO:0005930 | axoneme | 2 | 1 |
Related structures:
AlphaFold database: E9AJA8
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 23 |
GO:0006807 | nitrogen compound metabolic process | 2 | 23 |
GO:0008152 | metabolic process | 1 | 23 |
GO:0018193 | peptidyl-amino acid modification | 5 | 23 |
GO:0018208 | peptidyl-proline modification | 6 | 23 |
GO:0019538 | protein metabolic process | 3 | 23 |
GO:0036211 | protein modification process | 4 | 23 |
GO:0043170 | macromolecule metabolic process | 3 | 23 |
GO:0043412 | macromolecule modification | 4 | 23 |
GO:0044238 | primary metabolic process | 2 | 23 |
GO:0071704 | organic substance metabolic process | 2 | 23 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 23 |
GO:0006457 | protein folding | 2 | 10 |
GO:0009987 | cellular process | 1 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 23 |
GO:0003824 | catalytic activity | 1 | 23 |
GO:0016853 | isomerase activity | 2 | 23 |
GO:0016859 | cis-trans isomerase activity | 3 | 23 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 23 |
GO:0005488 | binding | 1 | 2 |
GO:0016018 | cyclosporin A binding | 4 | 2 |
GO:0033218 | amide binding | 2 | 2 |
GO:0042277 | peptide binding | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 220 | 224 | PF00656 | 0.242 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.375 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.330 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.372 |
CLV_PCSK_PC1ET2_1 | 136 | 138 | PF00082 | 0.301 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.448 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.410 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.373 |
CLV_Separin_Metazoa | 43 | 47 | PF03568 | 0.314 |
DOC_MAPK_gen_1 | 146 | 155 | PF00069 | 0.306 |
DOC_MAPK_HePTP_8 | 310 | 322 | PF00069 | 0.195 |
DOC_MAPK_MEF2A_6 | 148 | 157 | PF00069 | 0.307 |
DOC_MAPK_MEF2A_6 | 313 | 322 | PF00069 | 0.195 |
DOC_PP1_RVXF_1 | 162 | 168 | PF00149 | 0.295 |
DOC_PP1_RVXF_1 | 288 | 295 | PF00149 | 0.339 |
DOC_PP2B_LxvP_1 | 42 | 45 | PF13499 | 0.320 |
DOC_USP7_MATH_1 | 197 | 201 | PF00917 | 0.388 |
DOC_USP7_MATH_1 | 318 | 322 | PF00917 | 0.219 |
DOC_USP7_MATH_1 | 54 | 58 | PF00917 | 0.399 |
LIG_14-3-3_CanoR_1 | 105 | 113 | PF00244 | 0.515 |
LIG_14-3-3_CanoR_1 | 114 | 124 | PF00244 | 0.435 |
LIG_14-3-3_CanoR_1 | 282 | 287 | PF00244 | 0.294 |
LIG_BIR_III_4 | 258 | 262 | PF00653 | 0.236 |
LIG_BRCT_BRCA1_1 | 273 | 277 | PF00533 | 0.442 |
LIG_FHA_1 | 193 | 199 | PF00498 | 0.158 |
LIG_FHA_1 | 250 | 256 | PF00498 | 0.369 |
LIG_FHA_2 | 116 | 122 | PF00498 | 0.498 |
LIG_FHA_2 | 12 | 18 | PF00498 | 0.505 |
LIG_FHA_2 | 218 | 224 | PF00498 | 0.251 |
LIG_FHA_2 | 323 | 329 | PF00498 | 0.317 |
LIG_LIR_Apic_2 | 199 | 205 | PF02991 | 0.219 |
LIG_LIR_Apic_2 | 250 | 256 | PF02991 | 0.280 |
LIG_LIR_Gen_1 | 168 | 176 | PF02991 | 0.308 |
LIG_LIR_Gen_1 | 275 | 284 | PF02991 | 0.259 |
LIG_LIR_Gen_1 | 34 | 44 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 168 | 173 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 215 | 221 | PF02991 | 0.228 |
LIG_LIR_Nem_3 | 275 | 281 | PF02991 | 0.392 |
LIG_LIR_Nem_3 | 34 | 39 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 5 | 10 | PF02991 | 0.439 |
LIG_PDZ_Class_1 | 329 | 334 | PF00595 | 0.344 |
LIG_Pex14_1 | 166 | 170 | PF04695 | 0.348 |
LIG_PTB_Apo_2 | 26 | 33 | PF02174 | 0.314 |
LIG_PTB_Phospho_1 | 26 | 32 | PF10480 | 0.320 |
LIG_REV1ctd_RIR_1 | 215 | 223 | PF16727 | 0.222 |
LIG_SH2_CRK | 10 | 14 | PF00017 | 0.439 |
LIG_SH2_CRK | 170 | 174 | PF00017 | 0.256 |
LIG_SH2_CRK | 202 | 206 | PF00017 | 0.171 |
LIG_SH2_CRK | 253 | 257 | PF00017 | 0.256 |
LIG_SH2_CRK | 36 | 40 | PF00017 | 0.315 |
LIG_SH2_GRB2like | 27 | 30 | PF00017 | 0.344 |
LIG_SH2_NCK_1 | 170 | 174 | PF00017 | 0.242 |
LIG_SH2_NCK_1 | 202 | 206 | PF00017 | 0.158 |
LIG_SH2_PTP2 | 278 | 281 | PF00017 | 0.325 |
LIG_SH2_STAP1 | 170 | 174 | PF00017 | 0.236 |
LIG_SH2_STAP1 | 36 | 40 | PF00017 | 0.403 |
LIG_SH2_STAT3 | 131 | 134 | PF00017 | 0.303 |
LIG_SH2_STAT5 | 131 | 134 | PF00017 | 0.508 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.209 |
LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.294 |
LIG_SH2_STAT5 | 278 | 281 | PF00017 | 0.250 |
LIG_SH2_STAT5 | 291 | 294 | PF00017 | 0.250 |
LIG_SUMO_SIM_par_1 | 194 | 200 | PF11976 | 0.247 |
LIG_TRFH_1 | 202 | 206 | PF08558 | 0.158 |
LIG_TYR_ITSM | 6 | 13 | PF00017 | 0.418 |
LIG_WRC_WIRS_1 | 4 | 9 | PF05994 | 0.325 |
MOD_CK1_1 | 117 | 123 | PF00069 | 0.282 |
MOD_CK1_1 | 75 | 81 | PF00069 | 0.521 |
MOD_CK1_1 | 83 | 89 | PF00069 | 0.470 |
MOD_CK2_1 | 68 | 74 | PF00069 | 0.537 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.686 |
MOD_Cter_Amidation | 134 | 137 | PF01082 | 0.284 |
MOD_GlcNHglycan | 274 | 277 | PF01048 | 0.384 |
MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.406 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.557 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.502 |
MOD_GlcNHglycan | 98 | 101 | PF01048 | 0.616 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.359 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.280 |
MOD_GSK3_1 | 229 | 236 | PF00069 | 0.418 |
MOD_GSK3_1 | 318 | 325 | PF00069 | 0.412 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.741 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.507 |
MOD_N-GLC_1 | 114 | 119 | PF02516 | 0.526 |
MOD_N-GLC_1 | 272 | 277 | PF02516 | 0.314 |
MOD_N-GLC_2 | 180 | 182 | PF02516 | 0.297 |
MOD_NEK2_1 | 142 | 147 | PF00069 | 0.504 |
MOD_NEK2_1 | 217 | 222 | PF00069 | 0.301 |
MOD_NEK2_1 | 277 | 282 | PF00069 | 0.306 |
MOD_NEK2_1 | 72 | 77 | PF00069 | 0.564 |
MOD_NEK2_2 | 197 | 202 | PF00069 | 0.219 |
MOD_NEK2_2 | 239 | 244 | PF00069 | 0.330 |
MOD_PIKK_1 | 60 | 66 | PF00454 | 0.463 |
MOD_PKA_2 | 185 | 191 | PF00069 | 0.413 |
MOD_Plk_1 | 2 | 8 | PF00069 | 0.317 |
MOD_Plk_1 | 249 | 255 | PF00069 | 0.281 |
MOD_Plk_1 | 272 | 278 | PF00069 | 0.195 |
MOD_Plk_1 | 68 | 74 | PF00069 | 0.716 |
MOD_Plk_4 | 108 | 114 | PF00069 | 0.408 |
MOD_Plk_4 | 185 | 191 | PF00069 | 0.288 |
MOD_Plk_4 | 197 | 203 | PF00069 | 0.355 |
MOD_Plk_4 | 213 | 219 | PF00069 | 0.207 |
MOD_Plk_4 | 282 | 288 | PF00069 | 0.257 |
MOD_Plk_4 | 318 | 324 | PF00069 | 0.334 |
MOD_SUMO_for_1 | 40 | 43 | PF00179 | 0.329 |
MOD_SUMO_rev_2 | 117 | 124 | PF00179 | 0.422 |
TRG_DiLeu_BaEn_1 | 102 | 107 | PF01217 | 0.408 |
TRG_DiLeu_LyEn_5 | 102 | 107 | PF01217 | 0.380 |
TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.430 |
TRG_ENDOCYTIC_2 | 150 | 153 | PF00928 | 0.354 |
TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.236 |
TRG_ENDOCYTIC_2 | 278 | 281 | PF00928 | 0.236 |
TRG_ENDOCYTIC_2 | 291 | 294 | PF00928 | 0.234 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.330 |
TRG_Pf-PMV_PEXEL_1 | 105 | 110 | PF00026 | 0.334 |
TRG_Pf-PMV_PEXEL_1 | 219 | 223 | PF00026 | 0.360 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IL84 | Leptomonas seymouri | 55% | 100% |
A0A0N1PDY0 | Leptomonas seymouri | 26% | 100% |
A0A0S4IKA5 | Bodo saltans | 38% | 100% |
A0A3Q8ICB3 | Leishmania donovani | 29% | 100% |
A0A3R7M7E5 | Trypanosoma rangeli | 44% | 100% |
A0A3S5H7U6 | Leishmania donovani | 36% | 100% |
A0A3S7X325 | Leishmania donovani | 23% | 100% |
A0A3S7X410 | Leishmania donovani | 35% | 100% |
A0A3S7XB52 | Leishmania donovani | 35% | 100% |
A0A451EJ79 | Leishmania donovani | 90% | 100% |
A4H346 | Leishmania braziliensis | 81% | 100% |
A4HCI8 | Leishmania braziliensis | 28% | 100% |
A4HHU7 | Leishmania braziliensis | 25% | 100% |
A4HIW9 | Leishmania braziliensis | 34% | 100% |
A4HRE3 | Leishmania infantum | 90% | 100% |
A4I004 | Leishmania infantum | 29% | 100% |
A4I4Z7 | Leishmania infantum | 23% | 100% |
A4I698 | Leishmania infantum | 35% | 100% |
A4I935 | Leishmania infantum | 36% | 100% |
A4IDA1 | Leishmania infantum | 35% | 100% |
C9ZQE6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 100% |
C9ZXF5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9AC11 | Leishmania major | 89% | 100% |
E9AT91 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
E9AVX7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9B0C7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9B1F3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 100% |
E9B400 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
P0C1I2 | Rhizopus delemar (strain RA 99-880 / ATCC MYA-4621 / FGSC 9543 / NRRL 43880) | 31% | 100% |
Q26548 | Schistosoma mansoni | 29% | 100% |
Q4Q1A6 | Leishmania major | 35% | 100% |
Q4Q6Q9 | Leishmania major | 35% | 100% |
Q4Q7V7 | Leishmania major | 24% | 100% |
Q4QBK2 | Leishmania major | 29% | 100% |
Q8IXY8 | Homo sapiens | 30% | 100% |
V5B9Y6 | Trypanosoma cruzi | 43% | 100% |
V5BM49 | Trypanosoma cruzi | 29% | 100% |